Epidermal growth factor receptor in tumor angiogenesis

Hematol Oncol Clin North Am. 2004 Oct;18(5):1007-21, viii. doi: 10.1016/j.hoc.2004.06.002.


This article focuses on the preclinical evidence for activation of the epidermal growth factor receptor (EGFR) in promoting angiogenesis and the efficacy of anti-EGFR agents in inhibiting angiogenesis and tumor growth.

Publication types

  • Review

MeSH terms

  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / physiology*
  • Humans
  • Neoplasms / blood supply*
  • Neovascularization, Pathologic / physiopathology*
  • Neovascularization, Pathologic / prevention & control


  • ErbB Receptors